Skip to main content
. Author manuscript; available in PMC: 2014 Jan 13.
Published in final edited form as: Invert Neurosci. 2012 May 5;12(1):37–41. doi: 10.1007/s10158-012-0135-8

Table 2.

Efficacy of different anthelmintics against H. bakeri as compared to Cry5B in vivo (Modified from Hu and Aroian 2012)

Anthelmintic Dose given (μM/kg) Dose relative to Cry5B Day(s) treatment was given (PI = post infection) % Reduction in intestinal worm burden Publication references
Cry5B 0.7 1x 15 days PI 70 Hu et al. (2010a)
Levamisole 49 70x 12 days PI 90 Fonseca-Salamanca et al. (2003)
Ivermectin 5.7 8x 18 days PI 87 Githiori et al. (2003a)
Pyrantel 84 120x 18 days PI 99 Githiori et al. (2003b)
Mebendazole 75 107x 9–15 days PI 84 Wabo Pone et al. (2009)
Tribendimidine 2.2 3x 15 days PI 70 Hu et al. (2010a)